Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.7300
+0.0086 (1.19%)
Jan 30, 2026, 4:00 PM EST - Market closed
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $29.81 million as of February 2, 2026. Its market cap has decreased by -27.36% in one year.
Market Cap
29.81M
Enterprise Value
-32.90M
1-Year Change
-27.36%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $29.81M, a decrease of -94.85%. That is a compound annual growth rate of -46.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 29.81M | 4.27% |
| Dec 31, 2025 | 28.59M | -41.18% |
| Dec 31, 2024 | 48.60M | -65.85% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
| Apr 30, 2021 | 579.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Skye Bioscience | 32.38M |
| Outlook Therapeutics | 32.32M |
| Werewolf Therapeutics | 32.11M |
| Kyntra Bio | 31.88M |
| Dyadic International | 31.52M |
| AN2 Therapeutics | 30.96M |
| Cue Biopharma | 30.55M |
| ProMIS Neurosciences | 30.48M |